Related Experiment Video
Updated: Jun 16, 2026
03:19
Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Omega-3 fatty acids and cognitive function in women
Jennifer G Robinson1, Nkechinyere Ijioma, William Harris
1Lipid Research Clinic, 200 Hawkins Drive, SE 226 GH, Iowa City, IA 52242, USA. jennifer-g-robinson@uiowa.edu
Women'S Health (London, England)
|January 22, 2010
Summary
Omega-3 fatty acids, like docosahexaenoic acid, may support cognitive function in aging adults. Research suggests benefits for brain health, but more extensive studies are needed to confirm effects, especially for Alzheimer's disease.
Area of Science:
- Nutrition Science
- Neuroscience
- Gerontology
Background:
- Omega-3 fatty acids (FAs) are crucial for neuronal membrane structure and function.
- Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are key long-chain omega-3 FAs found in fish.
- These FAs exhibit neuroprotective effects, influencing neuronal function, inflammation, oxidation, and cell death.
Purpose of the Study:
- To evaluate the role of omega-3 fatty acids in maintaining cognitive function in aging individuals.
- To explore the potential of omega-3 FAs in preventing cognitive decline and conditions like Alzheimer's disease and vascular dementia.
- To assess the impact of DHA and EPA supplementation on cognitive performance in older adults.
Main Methods:
- Review of epidemiological studies linking fish consumption and omega-3 FA levels to cognitive health.
- Analysis of findings from small, short-term randomized controlled trials of DHA and/or EPA supplementation.
- Comparison of cognitive outcomes in cognitively intact, mild cognitive impairment, and Alzheimer's disease patient groups.
Main Results:
- Epidemiological data generally support a protective association between omega-3 FA intake and cognitive decline.
- Some short-term trials show positive effects of DHA/EPA supplementation on specific cognitive aspects in healthy older adults or those with mild cognitive impairment.
- Limited cognitive benefits were observed in participants with established Alzheimer's disease.
Conclusions:
- Omega-3 fatty acids show promise for supporting cognitive function during aging.
- Further large-scale, long-term clinical trials are necessary to definitively establish the efficacy of omega-3 FA supplementation for cognitive health and dementia prevention.
- Targeted research is needed to understand the differential effects of omega-3 FAs across the spectrum of cognitive decline, from intact cognition to Alzheimer's disease.
Related Concept Videos
03:38Structure of Lipids
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...